GHRP-6

For Research Use Only

Important Notice – Research Use Only All products offered are strictly intended for laboratory and scientific research purposes only. They are not approved by Health Canada and must not be used for human or veterinary consumption, therapeutic applications, or self-administration under any circumstances. Descriptions provided, including potential biological actions or benefits, are based on preliminary scientific research. These findings are experimental in nature and should not be interpreted as medical claims, therapeutic recommendations, or evidence of safety or efficacy. ⚠️ Regulatory Disclaimer Unauthorized health products have not been approved by Health Canada, which means they have not been assessed for safety, efficacy, or quality. Use of such products outside of controlled research environments may pose serious health risks.

GHRP-6 Peptide

Scientific Overview and benefits
GHRP-6 is a synthetic hexapeptide, an analog of met-enkephalin, that induces growth hormone (GH) secretion by activating ghrelin receptors (GHS-R1a) without exhibiting typical opioid activity. It functions as a potent growth hormone secretagogue.
Mechanism of Action
GHRP-6 binds GHS-R1a in the hypothalamus and pituitary, triggering a G-protein–mediated cascade (via Gαq/11, PLC, IP₃, and DAG) that elevates intracellular calcium and activates PKC, ultimately stimulating GH release. Experimental data suggest that its full efficacy depends on endogenous GHRH, as co-administration with GHRH yields synergistic effects. Additionally, GHRP-6 may interact with CD36 receptors, contributing to cell survival pathways and modulating lipid metabolism, inflammation, and angiogenesis.